TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

TrueCar Posts Another 1Q Loss, With In-Line Revenue
OPINION

4 Stocks Under $10 to Trade for Big Breakouts

  • By Roberto Pedone
  • Sep 17, 2015 2:10 PM EDT
PRESS RELEASES

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of CorMedix Inc. - CRMD

  • By PR Newswire
  • Mar 18, 2021 4:49 PM EDT
PRESS RELEASES

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of CorMedix Inc. - CRMD

  • By PR Newswire
  • Mar 12, 2021 5:35 AM EST
PRESS RELEASES

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of CorMedix Inc. - CRMD

  • By PR Newswire
  • Mar 3, 2021 3:01 PM EST
PRESS RELEASES

CorMedix Receives Complete Response Letter From FDA For DefenCath™ Catheter Lock Solution

  • By GlobeNewswire
  • Mar 1, 2021 8:30 AM EST
PRESS RELEASES

CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting For New Drug Application For Defencath Is Not Needed

  • By GlobeNewswire
  • Nov 18, 2020 8:30 AM EST
PRESS RELEASES

CorMedix Appoints Greg Duncan To Its Board Of Directors

  • By GlobeNewswire
  • Nov 2, 2020 8:30 AM EST
PRESS RELEASES

CorMedix To Participate In BIO Investor Forum Digital

  • By GlobeNewswire
  • Oct 8, 2020 9:00 AM EDT
PRESS RELEASES

CorMedix Appoints Paulo Costa To Its Board Of Directors

  • By GlobeNewswire
  • Sep 17, 2020 8:30 AM EDT
PRESS RELEASES

CorMedix Inc. Announces FDA Acceptance For Filing And Priority Review Of New Drug Application For Defencath

  • By GlobeNewswire
  • Aug 31, 2020 7:47 AM EDT
PRESS RELEASES

CorMedix Announces Pricing Of $20M Public Offering Of Common Stock

  • By GlobeNewswire
  • Jul 28, 2020 9:21 AM EDT
PRESS RELEASES

CorMedix Announces Proposed Public Offering Of Common Stock

  • By GlobeNewswire
  • Jul 27, 2020 4:05 PM EDT
PRESS RELEASES

CorMedix Inc. Reports Submission Of Defencath™ New Drug Application

  • By GlobeNewswire
  • Jul 8, 2020 8:30 AM EDT
PRESS RELEASES

CorMedix Inc. Announces Appointment Of Chief Financial Officer

  • By GlobeNewswire
  • May 11, 2020 8:30 AM EDT
PRESS RELEASES

CorMedix Inc. Announces Contract Extension Of Jack Armstrong As Executive Vice President And Head Of Technical Operations

  • By GlobeNewswire
  • Apr 23, 2020 8:15 AM EDT
PRESS RELEASES

CorMedix Completes Sale Of $5.5 Million Of NOL Tax Benefits Through New Jersey Technology Business Tax Certificate Transfer Program

  • By GlobeNewswire
  • Apr 22, 2020 8:00 AM EDT
PRESS RELEASES

CorMedix Approved To Sell $5.5 Million Of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

  • By GlobeNewswire
  • Feb 3, 2020 4:19 PM EST
PRESS RELEASES

CorMedix Inc. Announces FDA Grant Of Rolling Review Of Neutrolin® New Drug Application

  • By GlobeNewswire
  • Feb 3, 2020 8:15 AM EST
TrueCar Posts Another 1Q Loss, With In-Line Revenue
OPINION

4 Stocks Under $10 to Trade for Big Breakouts

  • By Roberto Pedone
  • Sep 17, 2015 2:10 PM EDT
Dating Sites: Best, Worst & Weirdest
OPINION

3 Stocks Under $10 Making Big Moves

  • By Roberto Pedone
  • Jul 30, 2015 2:49 PM EDT
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: SBW, HIO, ETG
MARKETS

Cormedix (CRMD): Today's Weak On High Volume Stock

  • By TheStreet Wire
  • Jun 30, 2015 10:02 AM EDT
Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

  • By Adam Feuerstein
  • Jun 19, 2015 6:00 AM EDT
State Street (STT) Stock Up Today Ahead of Friday's Earnings Release
MARKETS

CorMedix (CRMD) Stock Gains After Receiving Positive FDA Feedback for Neutrolin

  • By Tony Owusu
  • Jun 17, 2015 12:38 PM EDT
Jones Lang LaSalle (JLL) Reaches New Lifetime High Today
MARKETS

Cormedix (CRMD): Today's Weak On High Volume Stock

  • By TheStreet Wire
  • Jun 12, 2015 10:01 AM EDT
AirMedia Group (AMCN) In A Perilous Reversal
MARKETS

Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock

  • By TheStreet Wire
  • Jun 5, 2015 10:02 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.